论文部分内容阅读
目的：体会对亚急性甲状腺炎实施地塞米松治疗的价值。方法：遵从“平衡序贯法”分组，择 2017.2-2019.5 阶段内的 68 例亚急性甲状腺炎患者分为对照组（33 例，强的松常规治疗）和观察组（35 例，地塞米松治疗），观察临床疗效、临床指标消失用时、甲状腺功能以及红细胞沉降率。结果：观察组临床疗效高达 97.1%，显著较 78.7%的对照组高，P＜0.05。经治疗后观察组临床各指标消失时间较短，红细胞沉降率较低，甲状腺功能较好，P＜0.05。结论：对亚急性甲状腺炎开展药物治疗，建议采纳地塞米松，可有效提升临床疗效并改善甲状腺功能以及红细胞沉降率。“,”Objective: To evaluate the value of dexamethasone in the treatment of subacute thyroiditis. Methods: 68 patients with subacute thyroiditis from February 2017 to may 2019 were divided into the control group (33 cases, prednisone conventional treatment) and the observation group (35 cases, dexamethasone treatment). The clinical efficacy, the time of disappearance of clinical indicators, thyroid function and erythrocyte sedimentation rate were observed. Results: the clinical efficacy of the observation group was 97.1%, significantly higher than 78.7% of the control group, P < 0.05. After treatment, the disappearance time of clinical indicators in the observation group was shorter, erythrocyte sedimentation rate was lower, thyroid functionwas better, P < 0.05. Conclusion: dexamethasone is recommended for drug treatment of subacute thyroiditis, which can effectively improve the clinical efficacy, thyroid function and erythrocyte sedimentation rate